Literature DB >> 23509359

A new model for CD8+ T cell memory inflation based upon a recombinant adenoviral vector.

Beatrice Bolinger1, Stuart Sims, Geraldine O'Hara, Catherine de Lara, Elma Tchilian, Sonja Firner, Daniel Engeler, Burkhard Ludewig, Paul Klenerman.   

Abstract

CD8(+) T cell memory inflation, first described in murine CMV (MCMV) infection, is characterized by the accumulation of high-frequency, functional Ag-specific CD8(+) T cell pools with an effector-memory phenotype and enrichment in peripheral organs. Although persistence of Ag is considered essential, the rules underpinning memory inflation are still unclear. The MCMV model is, however, complicated by the virus's low-level persistence and stochastic reactivation. We developed a new model of memory inflation based on a β-galactosidase (βgal)-recombinant adenovirus vector. After i.v. administration in C57BL/6 mice, we observed marked memory inflation in the βgal96 epitope, whereas a second epitope, βgal497, undergoes classical memory formation. The inflationary T cell responses show kinetics, distribution, phenotype, and functions similar to those seen in MCMV and are reproduced using alternative routes of administration. Memory inflation in this model is dependent on MHC class II. As in MCMV, only the inflating epitope showed immunoproteasome independence. These data define a new model for memory inflation, which is fully replication independent, internally controlled, and reproduces the key immunologic features of the CD8(+) T cell response. This model provides insight into the mechanisms responsible for memory inflation and, because it is based on a vaccine vector, also is relevant to novel T cell-inducing vaccines in humans.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23509359      PMCID: PMC3672979          DOI: 10.4049/jimmunol.1202665

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  On the role of CD4+ T cells in the CD8+ T-cell response elicited by recombinant adenovirus vaccines.

Authors:  Teng Chih Yang; James Millar; Timothy Groves; Wenzhong Zhou; Natalie Grinshtein; Robin Parsons; Carole Evelegh; Zhou Xing; Yonghong Wan; Jonathan Bramson
Journal:  Mol Ther       Date:  2007-03-20       Impact factor: 11.454

2.  Rapid and sustained CD4(+) T-cell-independent immunity from adenovirus-encoded vaccine antigens.

Authors:  Peter J Holst; Christina Bartholdy; Annette Stryhn; Allan R Thomsen; Jan P Christensen
Journal:  J Gen Virol       Date:  2007-06       Impact factor: 3.891

Review 3.  T cell exhaustion.

Authors:  E John Wherry
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

4.  Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus.

Authors:  H G Zhang; Y M Wang; J F Xie; X Liang; H C Hsu; X Zhang; J Douglas; D T Curiel; J D Mountz
Journal:  Gene Ther       Date:  2001-05       Impact factor: 5.250

5.  Phenotypic analysis of antigen-specific T lymphocytes.

Authors:  J D Altman; P A Moss; P J Goulder; D H Barouch; M G McHeyzer-Williams; J I Bell; A J McMichael; M M Davis
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

6.  Cutting edge: shift in antigen dependence by an antiviral MHC class Ib-restricted CD8 T cell response during persistent viral infection.

Authors:  Phillip A Swanson; Amelia R Hofstetter; Jarad J Wilson; Aron E Lukacher
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

7.  Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus.

Authors:  Christopher M Snyder; Kathy S Cho; Elizabeth L Bonnett; Jane E Allan; Ann B Hill
Journal:  PLoS Pathog       Date:  2011-10-06       Impact factor: 6.823

8.  Prolonged activation of virus-specific CD8+T cells after acute B19 infection.

Authors:  Adiba Isa; Victoria Kasprowicz; Oscar Norbeck; Andrew Loughry; Katie Jeffery; Kristina Broliden; Paul Klenerman; Thomas Tolfvenstam; Paul Bowness
Journal:  PLoS Med       Date:  2005-11-01       Impact factor: 11.069

9.  Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.

Authors:  Andrew W Sylwester; Bridget L Mitchell; John B Edgar; Cara Taormina; Christian Pelte; Franziska Ruchti; Paul R Sleath; Kenneth H Grabstein; Nancy A Hosken; Florian Kern; Jay A Nelson; Louis J Picker
Journal:  J Exp Med       Date:  2005-09-05       Impact factor: 14.307

10.  Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease.

Authors:  B Ludewig; A F Ochsenbein; B Odermatt; D Paulin; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

View more
  29 in total

Review 1.  Herpesviral vectors and their application in oncolytic therapy, vaccination, and gene transfer.

Authors:  Susanne M Bailer; Christina Funk; André Riedl; Zsolt Ruzsics
Journal:  Virus Genes       Date:  2017-06-20       Impact factor: 2.332

Review 2.  Vaccine vectors: the bright side of cytomegalovirus.

Authors:  Andrea C Méndez; Cristina Rodríguez-Rojas; Margarita Del Val
Journal:  Med Microbiol Immunol       Date:  2019-03-21       Impact factor: 3.402

Review 3.  T cell responses to cytomegalovirus.

Authors:  Paul Klenerman; Annette Oxenius
Journal:  Nat Rev Immunol       Date:  2016-04-25       Impact factor: 53.106

4.  A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.

Authors:  Leo Swadling; Stefania Capone; Richard D Antrobus; Anthony Brown; Rachel Richardson; Evan W Newell; John Halliday; Christabel Kelly; Dan Bowen; Joannah Fergusson; Ayako Kurioka; Virginia Ammendola; Mariarosaria Del Sorbo; Fabiana Grazioli; Maria Luisa Esposito; Loredana Siani; Cinzia Traboni; Adrian Hill; Stefano Colloca; Mark Davis; Alfredo Nicosia; Riccardo Cortese; Antonella Folgori; Paul Klenerman; Eleanor Barnes
Journal:  Sci Transl Med       Date:  2014-11-05       Impact factor: 17.956

Review 5.  Fuel and brake of memory T cell inflation.

Authors:  Suzanne P M Welten; Nicolas S Baumann; Annette Oxenius
Journal:  Med Microbiol Immunol       Date:  2019-03-09       Impact factor: 4.148

6.  Systemic hematogenous maintenance of memory inflation by MCMV infection.

Authors:  Corinne J Smith; Holly Turula; Christopher M Snyder
Journal:  PLoS Pathog       Date:  2014-07-03       Impact factor: 6.823

7.  Cytomegalovirus Reinfections Stimulate CD8 T-Memory Inflation.

Authors:  Joanne Trgovcich; Michelle Kincaid; Alicia Thomas; Marion Griessl; Peter Zimmerman; Varun Dwivedi; Valerie Bergdall; Paul Klenerman; Charles H Cook
Journal:  PLoS One       Date:  2016-11-21       Impact factor: 3.240

8.  Modification of Antigen Impacts on Memory Quality after Adenovirus Vaccination.

Authors:  Julia M Colston; Beatrice Bolinger; Matthew G Cottingham; Sarah Gilbert; Paul Klenerman
Journal:  J Immunol       Date:  2016-03-04       Impact factor: 5.422

9.  CD73 is dispensable for the regulation of inflationary CD8+ T-cells after murine cytomegalovirus infection and adenovirus immunisation.

Authors:  Stuart Sims; Julia Colston; Beatrice Bolinger; Vince Emery; Paul Klenerman
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

10.  Adenoviral Vector Vaccination Induces a Conserved Program of CD8(+) T Cell Memory Differentiation in Mouse and Man.

Authors:  Beatrice Bolinger; Stuart Sims; Leo Swadling; Geraldine O'Hara; Catherine de Lara; Dilair Baban; Natasha Saghal; Lian Ni Lee; Emanuele Marchi; Mark Davis; Evan Newell; Stefania Capone; Antonella Folgori; Ellie Barnes; Paul Klenerman
Journal:  Cell Rep       Date:  2015-11-12       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.